Back to StakeholdersVisit Provider
Categories
2 domains / 4 areas / 2 specializations
Medical University Innsbruck
Data updated
Austria
4 Trials
Leading Austrian medical university in Innsbruck. Researchers here have investigated the structural biology of psilocybin-biosynthesizing enzymes with the aim of optimizing sustainable psilocybin production, while also contributing to clinical research as European psychedelic frameworks evolve.
Academic Research
0 papersPublished Papers
0
Trial Involvement
4
Distinct Focus Topics
0
Latest Publication
Unknown
Clinical Care Delivery Snapshot
Health Systems & HospitalsProvider Model
Health System / Hospital Program
Organization Status
Unknown
Psychedelic Services
Unknown
Service Coverage
Global
Service Profile
Care Settings
Hospital Outpatient
Payer Models
Unknown
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Backfilled profile for existing L2 clinical care delivery stakeholder.
Quick Facts
- Type
- Other
- HQ
- Austria
- Website
- Visit